1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Leukemia, Large Granular Lymphocytic in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
Leukemia, Large Granular Lymphocytic: A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watters, RJ | 1 |
| Fox, TE | 1 |
| Tan, SF | 1 |
| Shanmugavelandy, S | 1 |
| Choby, JE | 1 |
| Broeg, K | 1 |
| Liao, J | 1 |
| Kester, M | 1 |
| Cabot, MC | 1 |
| Loughran, TP | 1 |
| Liu, X | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Leukemia, Large Granular Lymphocytic
| Article | Year |
|---|---|
Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Ceramides; Dose-Response Relation | 2013 |